-
1
-
-
0030956673
-
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
-
Ridker PM, Cushman M, Stampfer MJ, Tracy RM, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-9.
-
(1997)
N Engl J Med
, vol.336
, pp. 973-979
-
-
Ridker, P.M.1
Cushman, M.2
Stampfer, M.J.3
Tracy, R.M.4
Hennekens, C.H.5
-
2
-
-
0032566401
-
Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
-
Ridker PM, Buring JE, Shih J, Matias M, Henneken CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98: 731-3.
-
(1998)
Circulation
, vol.98
, pp. 731-733
-
-
Ridker, P.M.1
Buring, J.E.2
Shih, J.3
Matias, M.4
Henneken, C.H.5
-
3
-
-
0032547326
-
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
-
Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280: 605-13.
-
(1998)
JAMA
, vol.280
, pp. 605-613
-
-
Hulley, S.1
Grady, D.2
Bush, T.3
Furberg, C.4
Herrington, D.5
Riggs, B.6
Vittinghoff, E.7
-
4
-
-
0029149174
-
Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors
-
The FINRISK Hemostasis Study
-
Salomaa V, Rasi V, Pekkanen J, Vahtera E, Jauhiainen M, Vartiainen E, Ehnholm C, Tuomilehto J, Myllyla G. Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors. The FINRISK Hemostasis Study. Arterioscler Thromb Vasc Biol 1995; 15: 1549-55.
-
(1995)
Arterioscler Thromb Vasc Biol
, vol.15
, pp. 1549-1555
-
-
Salomaa, V.1
Rasi, V.2
Pekkanen, J.3
Vahtera, E.4
Jauhiainen, M.5
Vartiainen, E.6
Ehnholm, C.7
Tuomilehto, J.8
Myllyla, G.9
-
5
-
-
0029983911
-
Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy
-
Myrup B, de Maat M, Rossing P, Gram J, Kluft C, Jespersen J. Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy. Thromb Haemost 1996; 81: 485-90.
-
(1996)
Thromb Haemost
, vol.81
, pp. 485-490
-
-
Myrup, B.1
De Maat, M.2
Rossing, P.3
Gram, J.4
Kluft, C.5
Jespersen, J.6
-
6
-
-
33745551242
-
Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens
-
Claus A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haemat 1957; 17: 237-46.
-
(1957)
Acta Haemat
, vol.17
, pp. 237-246
-
-
Claus, A.1
-
7
-
-
0030041585
-
How to deal with regression to the mean in intervention studies
-
Yudkin PL, Stratton IM. How to deal with regression to the mean in intervention studies. Lancet 1996; 347: 241-3.
-
(1996)
Lancet
, vol.347
, pp. 241-243
-
-
Yudkin, P.L.1
Stratton, I.M.2
-
8
-
-
0031443428
-
Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women - A randomized controlled trial
-
Scarabin PY, Alhencgelas M, Plubureau G, Taisne P, Agher R, Aiach M. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women - a randomized controlled trial. Arterioscler Thromb Vasc Biol 1997; 17: 3071-8.
-
(1997)
Arterioscler Thromb Vasc Biol
, vol.17
, pp. 3071-3078
-
-
Scarabin, P.Y.1
Alhencgelas, M.2
Plubureau, G.3
Taisne, P.4
Agher, R.5
Aiach, M.6
-
9
-
-
0032539907
-
Effect of postmenopausal hormone therapy on lipoprotein(a) concentration
-
PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions
-
Espeland MA, Marcovina SM, Miller V, Wood P, Wasilauskas C, Sherwin R, Schrott H, Bush TL. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions. Circulation 1998; 97: 979-86.
-
(1998)
Circulation
, vol.97
, pp. 979-986
-
-
Espeland, M.A.1
Marcovina, S.M.2
Miller, V.3
Wood, P.4
Wasilauskas, C.5
Sherwin, R.6
Schrott, H.7
Bush, T.L.8
-
10
-
-
2642712522
-
Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
-
Walsh BW, Kuller LH, Wild RA, Paul S, Farmer M, Lawence JB, Shah AS, Anderson PW. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA 1998; 279: 1445-51.
-
(1998)
JAMA
, vol.279
, pp. 1445-1451
-
-
Walsh, B.W.1
Kuller, L.H.2
Wild, R.A.3
Paul, S.4
Farmer, M.5
Lawence, J.B.6
Shah, A.S.7
Anderson, P.W.8
-
11
-
-
0032981919
-
Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women
-
Van Baal WM, Kenemans P, Emeis JJ, Schalkwijk CG, Van der Mooren MJ, Vischer UM, Stehouwer CDA. Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women. Fertil Steril 1999; 71: 663-70.
-
(1999)
Fertil Steril
, vol.71
, pp. 663-670
-
-
Van Baal, W.M.1
Kenemans, P.2
Emeis, J.J.3
Schalkwijk, C.G.4
Van Der Mooren, M.J.5
Vischer, U.M.6
Stehouwer, C.D.A.7
-
12
-
-
2842541523
-
Effects on haemostasis of hormone replacement therapy with transdermal and oral sequential medroxyprogesteron acetate: A 1-year, double-blind, placebo-controlled study
-
Writing group for the estradiol clotting factors study. Effects on haemostasis of hormone replacement therapy with transdermal and oral sequential medroxyprogesteron acetate: A 1-year, double-blind, placebo-controlled study. Thromb Haemost 1996; 75: 476-80.
-
(1996)
Thromb Haemost
, vol.75
, pp. 476-480
-
-
-
13
-
-
77957126077
-
Effects of estrogen or estrogen/progestin regimes on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Intervention (PEPI) trial
-
The writing group for the PEPI trial. Effects of estrogen or estrogen/progestin regimes on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Intervention (PEPI) trial. JAMA 1995; 273: 199-208.
-
(1995)
JAMA
, vol.273
, pp. 199-208
-
-
-
14
-
-
0031054058
-
Production of c-reactive protein and risk of coronary events in stable and unstable angina
-
Haverkate F, Thompson SG, Pyke SM, Gallimore JR, Pepys, MB. Production of c-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997; 349: 462-6.
-
(1997)
Lancet
, vol.349
, pp. 462-466
-
-
Haverkate, F.1
Thompson, S.G.2
Pyke, S.M.3
Gallimore, J.R.4
Pepys, M.B.5
-
15
-
-
0029983255
-
Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers
-
de Maat MP, Pietersma A, Kofflard M, Sluiter W, Kluft C. Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers. Atherosclerosis 1996; 121: 185-91.
-
(1996)
Atherosclerosis
, vol.121
, pp. 185-191
-
-
De Maat, M.P.1
Pietersma, A.2
Kofflard, M.3
Sluiter, W.4
Kluft, C.5
|